Log in or Sign up for Free to view tailored content for your specialty!
Neurorehabilitation News
Blackrock Neurotech acquires MindX to aid creation of brain-computer interface products
In a company press release, Blackrock Neurotech announced the acquisition of spatial computing software firm MindX to bolster its development of technologically advanced brain-computer interface products.
Study announced for digital therapeutic that improves sleep in stroke patients
Digital therapeutics company Big Health has announced a partnership with the University of Oxford for a new study evaluating Sleepio, an online program designed to improve sleep and mental health for stroke patients.
Log in or Sign up for Free to view tailored content for your specialty!
Endovascular brain-computer interface safe, effective for severe paralysis
PHILADELPHIA — An endovascular brain-computer interface allowed those who are paralyzed to perform computer-based activities, according to a presenter at the American Association of Neurological Surgeons annual meeting.
Longer dosing intervals of natalizumab safe, effective for MS patients
Most patients with relapsing-remitting MS who are stable on natalizumab every 4 weeks, can switch to a 6-week dosing regimen without losing efficacy, according to results of a clinical trial published in the Lancet Neurology.
Computerized diagnostic tool shows promise for early detection of cognitive impairment
A computerized diagnostic tool was able to distinguish patients with normal cognition, mild cognitive impairment and dementia and may be useful in detecting early signs of cognitive impairment, according to a study published in JMIR Aging.
FDA approves drug for adults with generalized myasthenia gravis
AstraZeneca has announced FDA approval of Ultomiris, a long-acting C5 complement inhibitor for the treatment of adults with generalized myasthenia gravis.
FDA grants orphan drug designation for frontotemporal dementia therapy
The FDA and European Commission have both granted orphan drug designation to AviadoBio for its new gene therapy to treat frontotemporal dementia, according to a company press release.
Ganaxolone reduces seizure frequency in patients with CDKL5 deficiency disorder
Ganaxolone was generally well tolerated and significantly reduced the frequency of seizures associated with CDKL5 deficiency disorder, according to a study published in The Lancet Neurology.
Familial hypercholesterolemia, long-term statin use not linked to risk for dementia
People with familial hypercholesterolemia and those on long-term, high-intensity statins had no greater risk for dementia than matched controls, per a study published in JAMA Network Open.
App-based mental exercises improve cognitive impairment
Those with amnestic mild cognitive impairment who used the BrainHQ app for visual speed and attention exercises improved neuropsychological measures of speed, attention, memory and connectivity.